Provides both assay services and neutralization kits, Including new mutant types spreading in UK and South Africa
Provide you the cell line development system with high performance, full traceability and real freedom commercial license.
Integrated ScFv and SdAb Discovery and CAR-T In Vitro Assay
Strategies Specially Designed for CAR Lead Discovery
From Research Grade to GMP
From Adherent to Suspension
From 2L to 200L
Fully Compliant, Fully Characterized
No Wait Time and Fast Turnaround
2,200L cGMP Capacity (6x200L and 2x500L single-use bioreactors)
Fully Single-Use System (AKTA ready +Mobius single-use filtration skids)
Zero-Crossover Production Lines
Comprehensive Technology Transfer
Our team and leaders have years of experience in global biopharma companies. Our PMs are trained scientists with PhD degree in the US and Europe.
We support flexible collaboration models that fit different projects to meet diversified customer needs. In projects with limited budget, upon request, we take on more roles throughout the project life cycle.
GenScript ProBio developed the distinguishing Phase-appropriate Compliance (PAC) quality system to meet worldwide stringent regulatory standards (including US-FDA/EU-EMA/China-NMPA), which will benefit our customers in a way of high quality, cost-effectiveness, efficiency and credibility.
Current capacity: up to 20 GCT IND and 400 L biologics. Total 16,800 L bioreactors by 2023.
SunRock Biopharma and GenScript ProBio Enter into a Collaboration Agreement to Develop Novel Monoclonal Antibody ProgramLearn More »
GenScript ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs Learn More »
Initium Therapeutics Strategically collaborates with GenScript ProBioLearn More »
GenScript ProBio CEO Brain Min Interviewed by the Medicine Maker Learn More »
GenScript ProBio is the bio-pharmaceutical CDMO segment of GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.
GenScript ProBio’s innovative solutions for antibody drug development include antibody drug discovery, antibody engineering and antibody characterization. In terms of biologics development service, GenScript ProBio has built a regulatory-compliant platform, from stable cell line development to clinical manufacturing services, providing high quality material for IND and clinical trials. GenScript ProBio’s total gene and cell therapy solution covers CMC of plasmid and virus for IND filing as well as clinical manufacturing and commercial manufacturing.
Toward the mission of “Innovation through Collaboration”, GenScript ProBio is committed to helping customers significantly lower R&D costs and building a healthier future.